RxDoctor Payments Data

Ofer Jacobowitz, PhD

Sleep Medicine · New York, NYNPI 1285617381

Payments from drug & device makers

What this record shows

This record is dominated by speaking fees: $97,919 of the $140,795 with a category attached, or 69.5%. Livanova USA, Inc. accounts for 81.8% of it on its own, with 27 other manufacturers making up the rest. Among sleep medicine clinicians in NY with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$140,795in general payments, 2019–2025

Across 199 payments — averaging $707.51 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Livanova USA, Inc.$115K
  • Aerin Medical Inc.$22K
  • Optinose US, Inc.$555
  • Jazz Pharmaceuticals Inc.$526
  • Sanofi$370
  • Somnomed Inc.$353
  • plus $2K from 22 others
$30,935in research payments, 2019–2025

Across 34 payments — averaging $909.86 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Livanova USA, Inc.$31K

What the payments were for

  • Consulting fees$37,50027%
  • Speaking & faculty fees$97,91970%
  • Food & beverage$5,3764%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$140,795 in reported general payments places this provider in the 95th percentile of 81 sleep medicine providers in New York.

See all sleep medicine providers in New York

Medicare billing

Part B allowed, 2024
$133,727
Medicare patients
237
Services billed
684

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Azelastine Hcl85$1,626
Montelukast Sodium13$632
Fluticasone Propionate37$394
Zolpidem Tartrate17$199

Paid to pharmacies, not to this prescriber.

Other sleep medicine in New York

See the full list for New York

Where these figures come from

Is this you, or does something look wrong? →